Amgen is proud to be a part of the American College of Cardiology's 70th Annual Scientific Session & Expo. While you're here, you can explore the latest scientific information and disease state education from Amgen, and learn about Amgen's long-term commitment to developing and delivering transformative medicines for patients with cardiovascular disease.
Overview of the mechanism of LDL-C regulation and the role of PCSK9.
Speakers: Dominick J. Angiolillo, MD, PhD, FACC | Carl (Chip) Lavie, Jr, MD, FACC
Watch how LDL-C levels recommended by multiple cholesterol guidelines have decreased over time and understand current recommendations for very high-risk patients.